Exhibit

0003-EX-TU-2015 Text Documents

Medtronic, Inc.

2015-01-14ELS_157684

DESCRIPTION OF APPLICATIONS By this application, the parties seek Federal Communication Commission (“FCC”) consent to a proposed transaction affecting the FCC experimental radio licenses issued in the table below. Call Sign OET License File No. Application File No. NA NA 0003-EX-TU-2015 (Parent Application) WE2XAA 0014-EX-RR-2012 0005-EX-TC-2015 WG2XFE 0175-EX-ML-2012 0006-EX-TC-2015 WG2XNT 0017-EX-ML-2014 0007-EX-TC-2015 WH2XBD 0096-EX-PL-2014 0008-EX-TC-2015 On January 6, 2015, the shareholders of Medtronic, Inc. approved an agreement between Medtronic and Covidien plc for Medtronic to acquire Covidien through the formation of a new holding company to be renamed Medtronic plc.1 Medtronic is the global leader in medical technology that serves hospitals, physicians, clinicians, and patients in more than 140 countries worldwide. Covidien is a global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien also develops, manufactures and sells a diverse range of industry-leading medical device and supply products. Upon consummation of the proposed transaction, both Medtronic, Inc., and Covidien plc will become wholly-owned, indirect subsidiaries of Medtronic plc. Following the merger, the former shareholders of Medtronic, Inc. are expected to own approximately 70 % and the former shareholders of Covidien are expected to own approximately 30% of the outstanding ordinary shares of Medtronic plc. By the above-referenced applications, the parties seek FCC consent for the pro forma transfer of control of the licenses currently held by Medtronic from the current shareholders of Medtronic, Inc., to the shareholders of Medtronic plc. PUBLIC INTEREST STATEMENT The parties submit that the public interest would be served by the approval of the requested application. FCC consent to the transaction would facilitate continued operations of the licensee. 13822755.1 1 See generally http://newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle&ID=2003657 (visited 1/9/2015).


Document Created: 2015-01-14 11:19:46
Document Modified: 2015-01-14 11:19:46
© 2025 FCC.report
This site is not affiliated with or endorsed by the FCC